Genomics and Proteomics in Predicting Cancer Outcomes

Surgical Oncology Clinics of North America

Volumn 17, Issue 2, 2008, Pages 257-277

  Parikh, Alexander A ^a   Johnson, J Chad ^a   Merchant, Nipun B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RECURRENCE; CANCER THERAPY; DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENETIC PROCEDURES; GENOMICS; HUMAN; PARAMETER; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; VALIDATION PROCESS;

DNA, NEOPLASM; GENOMICS; HUMANS; MASS SPECTROMETRY; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; RNA, NEOPLASM; TREATMENT OUTCOME;

EID: 41049084986     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.12.001     Document Type: Review

References (86)

1. Nielsen T.O., West R.B., Linn S.C., et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359 9314 (2002) 1301-1307
2. Ross D.T., Scherf U., Eisen M.B., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24 3 (2000) 227-235
3. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 5439 (1999) 531-537
4. Khan J., Simon R., Bittner M., et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58 22 (1998) 5009-5013
5. Chung C.H., Levy S., Chaurand P., et al. Genomics and proteomics: emerging technologies in clinical cancer research. Crit Rev Oncol Hematol 61 1 (2007) 1-25
6. Alon U., Barkai N., Notterman D.A., et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 96 12 (1999) 6745-6750
7. Bloom G., Yang I.V., Boulware D., et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 164 1 (2004) 9-16
8. Eschrich S., Yang I., Bloom G., et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23 15 (2005) 3526-3535
9. Perou C.M., Jeffrey S.S., van de Rijn M., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96 16 (1999) 9212-9217
10. Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 354 23 (2006) 2463-2472
11. Beer D.G., Kardia S.L., Huang C.C., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 8 (2002) 816-824
12. Kihara C., Tsunoda T., Tanaka T., et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61 17 (2001) 6474-6479
13. Lonning P.E., Sorlie T., Perou C.M., et al. Microarrays in primary breast cancer-lessons from chemotherapy studies. Endocr Relat Cancer 8 3 (2001) 259-263
14. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 19 (2001) 10869-10874
15. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 6871 (2002) 530-536
16. Copland J.A., Davies P.J., Shipley G.L., et al. The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res 58 (2003) 25-53
17. DeRisi J., Penland L., Brown P.O., et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14 4 (1996) 457-460
18. Schena M., Shalon D., Davis R.W., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 5235 (1995) 467-470
19. Wang E., Miller L.D., Ohnmacht G.A., et al. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 18 4 (2000) 457-459
20. Best C.J., and Emmert-Buck M.R. Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn 1 1 (2001) 53-60
21. Gillespie J.W., Ahram M., Best C.J., et al. The role of tissue microdissection in cancer research. Cancer J 7 1 (2001) 32-39
22. Brown P.O., and Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 21 1 Suppl (1999) 33-37
23. Shalon D., Smith S.J., and Brown P.O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 6 7 (1996) 639-645
24. Ekins R., and Chu F.W. Microarrays: their origins and applications. Trends Biotechnol 17 6 (1999) 217-218
25. Gershon D. Microarray technology: an array of opportunities. Nature 416 6883 (2002) 885-891
26. Fodor S.P., Read J.L., Pirrung M.C., et al. Light-directed, spatially addressable parallel chemical synthesis. Science 251 4995 (1991) 767-773
27. de Longueville F., Atienzar F.A., Marcq L., et al. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 75 2 (2003) 378-392
28. Quackenbush J. Microarray data normalization and transformation. Nat Genet 32 Suppl 4 (2002) 496-501
29. Warren L., Bryder D., Weissman I.L., et al. Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci U S A 103 47 (2006) 17807-17812
30. Schadt E.E., Li C., Ellis B., et al. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 34 Suppl 37 (2001) 120-125
31. Yang I.V., Chen E., Hasseman J.P., et al. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 3 11 (2002) 62.1-62.12
32. Statnikov A., Aliferis C.F., Tsamardinos I., et al. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics 21 5 (2005) 631-643
33. Eisen M.B., Spellman P.T., Brown P.O., et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 25 (1998) 14863-14868
34. Ball C.A., Sherlock G., Parkinson H., et al. Standards for microarray data. Science 298 5593 (2002) 539
35. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29 4 (2001) 365-371
36. Shi L., Reid L.H., Jones W.D., et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24 9 (2006) 1151-1161
37. Fan J., and Niu Y. Selection and validation of normalization methods for c-DNA microarrays using within-array replications. Bioinformatics 23 18 (2007) 2391-2398
38. Spellman P.T., Miller M., Stewart J., et al. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol 3 9 (2002) 46.1-46.9
39. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 6769 (2000) 503-511
40. Bullinger L., Dohner K., Bair E., et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350 16 (2004) 1605-1616
41. Yeoh E.J., Ross M.E., Shurtleff S.A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1 2 (2002) 133-143
42. Ramaswamy S., Tamayo P., Rifkin R., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98 26 (2001) 15149-15154
43. Tothill R.W., Kowalczyk A., Rischin D., et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res 65 10 (2005) 4031-4040
44. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
45. Jeffrey S.S., Lonning P.E., and Hillner B.E. Genomics-based prognosis and therapeutic prediction in breast cancer. J Natl Compr Canc Netw 3 3 (2005) 291-300
46. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 9460 (2005) 671-679
47. Cardoso J., Boer J., Morreau H., et al. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 1775 1 (2007) 103-137
48. Barrier A., Boelle P.Y., Roser F., et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24 29 (2006) 4685-4691
49. Wang Y., Jatkoe T., Zhang Y., et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22 9 (2004) 1564-1571
50. Lanza G., Gafa R., Santini A., et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24 15 (2006) 2359-2367
51. Locker G.Y., Hamilton S., Harris J., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24 33 (2006) 5313-5327
52. Popat S., and Houlston R.S. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41 14 (2005) 2060-2070
53. Gianni L., Zambetti M., Clark K., et al. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol 23 29 (2005) 7265-7277
54. Ayers M., Symmans W.F., Stec J., et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22 12 (2004) 2284-2293
55. Chang J.C., Wooten E.C., Tsimelzon A., et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362 9381 (2003) 362-369
56. Jones J., and Libermann T.A. Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin Cancer Res 13 2 Pt 2 (2007) 685s-692s
57. Unlu M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 11 (1997) 2071-2077
58. Alban A., David S.O., Bjorkesten L., et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 1 (2003) 36-44
59. Lilley K.S., and Friedman D.B. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 1 4 (2004) 401-409
60. Pandey A., and Mann M. Proteomics to study genes and genomes. Nature 405 6788 (2000) 837-846
61. Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 55 2 (1986) 244-248
62. Wan W.H., Fortuna M.B., and Furmanski P. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 103 1 (1987) 121-129
63. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 7 (1998) 844-847
64. Wang S., Saboorian M.H., Frenkel E.P., et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol 116 4 (2001) 495-503
65. Hillenkamp F., Karas M., Beavis R.C., et al. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal Chem 63 24 (1991) 1193A-1203A
66. Karas M., and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60 20 (1988) 2299-2301
67. Fenn J.B., Mann M., Meng C.K., et al. Electrospray ionization for mass spectrometry of large biomolecules. Science 246 4926 (1989) 64-71
68. Stoeckli M., Chaurand P., Hallahan D.E., et al. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7 4 (2001) 493-496
69. Chaurand P., Fouchecourt S., DaGue B.B., et al. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry. Proteomics 3 11 (2003) 2221-2239
70. Reyzer M.L., Hsieh Y., Ng K., et al. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 38 10 (2003) 1081-1092
71. Reyzer M.L., Caldwell R.L., Dugger T.C., et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 64 24 (2004) 9093-9100
72. Chen G., Gharib T.G., Huang C.C., et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 8 7 (2002) 2298-2305
73. Soltys S.G., Le Q.T., Shi G., et al. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 10 14 (2004) 4806-4812
74. Wadsworth J.T., Somers K.D., Cazares L.H., et al. Serum protein profiles to identify head and neck cancer. Clin Cancer Res 10 5 (2004) 1625-1632
75. Wadsworth J.T., Somers K.D., Stack Jr. B.C., et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 130 1 (2004) 98-104
76. Ornstein D.K., Rayford W., Fusaro V.A., et al. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 172 4 Pt 1 (2004) 1302-1305
77. Wang X., Yu J., Sreekumar A., et al. Autoantibody signatures in prostate cancer. N Engl J Med 353 12 (2005) 1224-1235
78. Schwartz S.A., Weil R.J., Johnson M.D., et al. Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10 3 (2004) 981-987
79. Chaurand P., Sanders M.E., Jensen R.A., et al. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 165 4 (2004) 1057-1068
80. Schwartz S.A., Weil R.J., Thompson R.C., et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 65 17 (2005) 7674-7681
81. Yanagisawa K., Shyr Y., Xu B.J., et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362 9382 (2003) 433-439
82. Jacquemier J., Ginestier C., Rougemont J., et al. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res 65 3 (2005) 767-779
83. Gharib T.G., Chen G., Wang H., et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 4 5 (2002) 440-448
84. Chen Y., Shi G., Xia W., et al. Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Res 64 20 (2004) 7302-7310
85. Friedman D.B., Hill S., Keller J.W., et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4 3 (2004) 793-811
86. Sheehan K.M., Calvert V.S., Kay E.W., et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 4 4 (2005) 346-355